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Abstract
It is important to distinguish liver metastases from incidental benign liver lesions which may be present in patients
with cancer. In a minority of cases, sonography or CT may be sufficient to characterise benign lesions, but the range
of sequences and contrast media available for liver MRI provides the opportunity for more specific diagnosis in the
great majority of cases. Biopsy is rarely needed.
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Introduction
Liver imaging is used not only for staging cancer
patients, but also for assessment of response to treat-
ment, for re-staging after treatment or with suspected
recurrence, and for surveillance during remission. If liver
abnormalities are shown, the differential diagnosis of
metastatic disease from benign or incidental lesions may
have a critical influence on the subsequent management
of the patient. Since the widespread introduction of
liver imaging for routine clinical investigation, it has
become clear that incidental benign liver lesions are
not rare. One useful practical guideline is that small
(<15 mm) lesions discovered incidentally in patients
with no known primary malignancy are virtually always
benign. However, in patients with known malignant
disease there is a small incidence of metastases whose CT
appearances overlap with those of benign lesions. Larger
benign lesions are less problematic, but at all sizes the
MR appearances are more characteristic.
Liver cysts
Simple cysts are round unless deformed by more rigid
adjacent structures. Their contents are anechoic on
ultrasound, show watery attenuation on CT, low signal on
T1w MRI and bright signal on conventional T2, which
is maintained on more heavily T2w sequences. Contrast
enhancement produces no change—an enhancing rim
raises the suspicion of necrotic metastasis, or in the
appropriate clinical context, abscess.
Haemangiomas
Characteristic appearances of haemangiomas are well
established—they are hyper-echoic on sonography and
show geographic shape with low attenuation on un-
enhanced CT and on T1w MRI. Their intense signal
on conventional T2w MRI is maintained with more
heavy T2 weighting (TE = 180 msec or HASTE). With
contrast-enhanced CT or gadolinium-enhanced MRI,
the lesions show intense nodular enhancement at the
periphery, followed by centripetal infilling over the next
5–10 min. Some larger lesions contain a central nodule
of hyalinized scar tissue which never enhances. The
discontinuity of the peripheral nodular enhancement is a
specific feature, and peripheral wash-out does not occur.
In contrast, metastases with necrotic centres are usually
round in shape and although they may show peripheral
enhancement, the ring is more uniform. Whilst delayed
enhancement of the necrotic centre of such lesions is not
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uncommon, the brightly enhancing peripheral ring fades
fairly rapidly. Some small haemangiomas show uniform
and rapid enhancement starting in the arterial phase,
similar to the appearance of small hepatocellular lesions,
but they show the distinguishing feature of intensely
bright signal on T2w MRI, in contrast to the iso-intense
or mildly hyper-intense appearance of small benign
hepatocellular lesions. Other atypical haemangiomas
include small lesions with centrifugal enhancement from
a single vascular nodule (central dot sign) and in other
cases the lesion may be predominantly fibrous, so
enhancement is patchy and delayed, with little of the
typical peripheral nodular vascularity.
Fatty change
Fatty infiltration is often heterogeneous and sometimes
focal; in other cases small focal areas of liver parenchyma
may be spared from fatty change. On sonography, either
focal fatty change or focal sparing can produce lesions
which are difficult to distinguish from metastases. One
helpful feature with focal fatty change or sparing is that
there is usually no mass effect—vessels run normally
through the apparently abnormal areas. Focal fat may
be recognisable on CT by its geographic distribution,
normal contrast enhancement, and the lack of a mass
effect, but a more reliable diagnosis can be made on
MRI. In patients with diffuse fatty change, metastases
may be obscured on CT because their low attenuation
is matched by the low attenuation of the surrounding
liver. Occasionally, a ring of liver tissue immediately
surrounding the lesion may be spared from fatty change,
producing an irregular halo of denser tissue within an
otherwise homogeneous liver. This appearance can be
seen with haemangiomas in a fatty liver, as well as
with metastases. Using in-phase and opposed-phase T1w
sequences, MRI offers a rapid and reliable approach for
the recognition of focal fat, and reveals metastatic lesions
in the diffusely fatty liver. Where any diagnostic doubt
remains, liver-specific contrast agents may be given.
Focal nodular hyperplasia (FNH)
With the widespread use of dual-phase CT, multi-
phase contrast-enhanced MR, and the recent introduction
of vascular contrast agents in sonography has come
a realisation that focal nodular hyperplasia (FNH) is
not rare. Larger lesions typically show a rounded or
lobulated shape with clear-cut margin, a mass effect
displacing adjacent vessels, and a central scar sometimes
with radiating spokes towards the periphery. Their
echogenicity, attenuation and signal characteristics are
little different to those of normal liver tissue. The lesions
show marked arterial phase contrast enhancement which
usually fades rapidly to become iso-intense in the portal
phase, although occasionally increased enhancement
lasts for several minutes. Delayed enhancement of the
central scar is characteristic. Lesions smaller than about
2 cm are often homogeneous with no central scar, but
show the same enhancement characteristics. It is not
rare for these small lesions to be multiple, and they
may co-exist with other benign lesions. When found in
patients with known malignancy, a confident diagnosis of
FNH requires the demonstration of intact liver function
within the lesion. The most effective method is to
use superparamagnetic iron oxide (SPIO) enhancement.
Some FNH lesions will take up as much SPIO as normal
liver, so the lesion appears black on the post-contrast T2w
images. In other cases the lesion may take up some SPIO,
but less than the surrounding liver, so that the lesion
becomes more apparent after contrast. In these cases it is
important to use the same T2w sequence before and after
SPIO, and to measure the change in signal intensity in
both liver and lesion. If the lesion shows substantial SPIO
uptake (more than 40–50% of that taken up by the liver),
it may be regarded as benign. Metastases do not take
up SPIO, but well-differentiated hepatocellular cancers
may take up just a little. Another approach is to use one
of the hepatocellular MR contrast agents (mangafodipir,
gadobenate, or gadoxetic acid). All of these agents are
taken up by the functioning hepatocytes present in FNH
lesions (and also in well-differentiated HCC), but because
there is no biliary excretory pathway, the lesions retain
the contrast for much longer than the normal liver, so
becoming brighter on delayed T1w images.
Focal perfusion artefacts
Peripheral wedge-shaped areas of abnormal perfusion,
usually seen only in the arterial dominant phases of
enhanced CT and MRI, are probably caused by segmental
portal vein occlusion, which in some cases is associated
with parenchymal tumour deposits; in other cases no
cause can be found. Such transient hepatic attenuation
defects (THADs) may also be associated with parenchy-
mal oedema within the liver, which appears hyper-intense
on T2w MRI. Around the periphery of segment 4,
particularly just to the right of the falciform ligament
anteriorly, and also anterior to the bifurcation of the portal
vein, small areas of liver parenchyma may receive non-
portal venous supply from the parabiliary venous plexus
and from anomalous drainage of gastric, duodenal and
pancreatic veins. This can produce small nodules of focal
fatty change in these areas, or more commonly may result
in small areas of altered enhancement after contrast.
Other benign malformation
Biliary microhamartomas (von Meyenburg complexes)
show imaging characteristics which overlap between
cysts and haemangiomas. These biliary malformations
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are often irregular or even angular in shape, and usually
only a few millimetres in diameter.
Conclusions and key points
(1) Incidental benign lesions are relatively common
in patients with malignant disease, and must be
distinguished from metastatic disease in order to
avoid erroneous management.
(2) Focal fat, focal sparing and haemangiomas may be
diagnosed on sonography or CT if they are typical,
but in other cases MRI is usually decisive.
(3) FNH can be diagnosed with confidence using liver-
specific MR contrast agents.
(4) Discriminating small cysts and haemangiomas
from metastases is best done with MRI, using
a heavily T2w sequence followed by dynamic
gadolinium-enhanced T1.
(5) Tiny lesions which appear on CT to have an angular
shape and low attenuation will usually be biliary
microhamartomas.
Further Reading
[1] Jones EC, Chezmar JL, Nelson RC, Bernardino ME. The
frequency and significance of small (<15 mm) hepatic lesions
detected by CT. AJR 1992; 158: 535–9.
[2] Schwarz LH, Gandras EJ, Colangelo SM, Ercolani MC,
Panicek DM. Prevalence and importance of small hepatic lesions
found at CT in patients with cancer. Radiology 1999; 210: 71–4.
[3] Ito K, Mitchell DG, Outwater EK, Szklaruk J, Sadek AG.
Hepatic lesions: discrimination of non-solid, benign lesions from
solid, malignant lesions with heavily T2-weighted fast spin-echo
MR imaging. Radiology 1997; 204: 729–37.
[4] Mahfouz AE, Hamm B, Wolf KJ. Peripheral washout: a sign
of malignancy on dynamic gadolinium-enhanced MR images of
focal liver lesions. Radiology 1994; 190: 49–52.
[5] Lev-Toaff AS, Bach AM, Wechsler RJ, Hilpert PL, Gatalica Z,
Rubin R. The radiologic and pathologic spectrum of biliary
hamartomas. AJR 1995; 165: 309–13.
[6] Schlund JF, Semelka RC, Kettritz U, Eisenberg LB, Lee JK.
Transient increased segmental hepatic enhancement distal
to portal vein obstruction on dynamic gadolinium-enhanced
gradient echo MR images. J Magn Reson Imaging 1995; 4:
375–7.
[7] Bluemke DA, Soyer P, Fishman EK. Non-tumorous low-
attenuation defects in the liver on helical CT during arterial
portography: frequency, location, and appearance. AJR 1995;
164: 1141–5.
